▶ 調査レポート

バイオ治療用糖タンパク質の世界市場 2019年

• 英文タイトル:Global Bio-Therapeutic Glycoproteins Sales Market Report 2019

QYResearchが調査・発行した産業分析レポートです。バイオ治療用糖タンパク質の世界市場 2019年 / Global Bio-Therapeutic Glycoproteins Sales Market Report 2019 / QYR9G05815資料のイメージです。• レポートコード:QYR9G05815
• 出版社/出版日:QYResearch / 2019年8月12日
• レポート形態:英文、PDF、104ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥424,000 (USD4,000)▷ お問い合わせ
  Enterprise License¥848,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、バイオ治療用糖タンパク質の世界市場について調査・分析し、バイオ治療用糖タンパク質のメーカー別販売量、市場シェア分析、種類別販売分析(抗血清、サイトカイン、凝固因子、ホルモン、酵素、酵素阻害剤)、用途別販売分析(Oncology and Haematology、Diabetes、Cardiology、Inflammatory Diseases、Others)、地域別販売分析(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・バイオ治療用糖タンパク質市場概要
・バイオ治療用糖タンパク質のメーカー別販売量・メーカー別シェア
・バイオ治療用糖タンパク質の種類別販売量(抗血清、サイトカイン、凝固因子、ホルモン、酵素、酵素阻害剤)
・バイオ治療用糖タンパク質の用途別販売量(Oncology and Haematology、Diabetes、Cardiology、Inflammatory Diseases、Others)
・バイオ治療用糖タンパク質の地域別販売量・市場シェア
・バイオ治療用糖タンパク質のアメリカ市場規模(2014年-2019年)
・バイオ治療用糖タンパク質のヨーロッパ市場規模(2014年-2019年)
・バイオ治療用糖タンパク質の中国市場規模(2014年-2019年)
・バイオ治療用糖タンパク質の日本市場規模(2014年-2019年)
・バイオ治療用糖タンパク質の東南アジア市場規模(2014年-2019年)
・バイオ治療用糖タンパク質のインド市場規模(2014年-2019年)
・バイオ治療用糖タンパク質メーカー分析(企業概要、製品概要、販売量、売上、価格等)
・バイオ治療用糖タンパク質のコスト分析
・バイオ治療用糖タンパク質販売チャネル、流通業者、顧客
・バイオ治療用糖タンパク質の世界市場動向・機会・成長要因・課題
・バイオ治療用糖タンパク質の種類別世界市場予測(抗血清、サイトカイン、凝固因子、ホルモン、酵素、酵素阻害剤)
・バイオ治療用糖タンパク質の用途別世界市場予測(Oncology and Haematology、Diabetes、Cardiology、Inflammatory Diseases、Others)
・バイオ治療用糖タンパク質のアメリカ市場予測(2019年-2025年)
・バイオ治療用糖タンパク質のヨーロッパ市場予測(2019年-2025年)
・バイオ治療用糖タンパク質の中国市場予測(2019年-2025年)
・バイオ治療用糖タンパク質の日本市場予測(2019年-2025年)
・バイオ治療用糖タンパク質の東南アジア市場予測(2019年-2025年)
・バイオ治療用糖タンパク質のインド市場予測(2019年-2025年)
...

Bio-Therapeutic Glycoproteins are bioactive compounds with carbohydrates attached to proteins. Glycan is the specific site where carbohydrate attaches to proteins and process of production is called glycosylation. Bio-therapeutic glycoproteins produced with glycan moieties that are similar to natural mammal glycans. The most common types are glycosylation O-linked and N-linked that are mainly depends on protein sequence attachment. Carbohydrates linked to proteins through either α and β linkages. Glycosylation is an important process of bio-therapeutic glycoproteins because it is critically modulated into bioactivity, stability, solubility against proteolysis, yield, clearance rate from circulation and immunogenicity. The bio-therapeutic glycoproteins mainly produced by yeast expression systems, insect cells, mammalian systems, and plant-based expression systems. In yeast expression systems, yeast is cultured chemically to scale up fermentation to an industrial level. Yeast and human share same N-glycan’s linkage. Insect cells represent an alternative system for expression of recombinant bio-therapeutic proteins. Later recombinant proteins are separated from insect cells. Mammalian Systems are used to produce complex bio-therapeutic glycoproteins. Most of the FDA approved bio-therapeutic glycoproteins derived from mammalian systems. Plant-based expression systems used for the scale-up production of glycoproteins. Among all systems, mammalian systems are well established in pharmaceuticals. Some examples of bio-therapeutic glycoproteins include tocilizumab, bevacizumab, adalimumab, etc.The potential benefits of Bio-Therapeutic Glycoproteins have been a subject of rising industrial interest in the context of wide range application. So, far they include several protein classes like antisera, cytokines, clotting factors, hormones, enzymes and enzyme inhibitors have been best suited physiologically. The trend of industrial developments likely continues alongside with growing knowledge about the functions of bio-therapeutic glycoproteins. Bio-Therapeutic Glycoproteins are a fastest growing field in the pharmaceutical industry due to a wide range of applicability. The mammalian expression system is used to produce glycoproteins that coded with human-like glycans. Bio-Therapeutic glycoproteins represent an integrated treatment for most of the autoimmune disorders, cancers, replacement therapies like hormone and enzyme substituted. All these benefits of glycoproteins drive the robust growth of the Bio-Therapeutic Glycoproteins market.

The global Bio-Therapeutic Glycoproteins market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report studies the global Bio-Therapeutic Glycoproteins market status and forecast, categorizes the global Bio-Therapeutic Glycoproteins market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
Genentech
Hoffmann-La Roche
Genzyme Corp
Abbott Laboratories
Amgen
Biogen
Merck
GlaxoSmithKline
Novartis Pharmaceuticals Corp

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
Antisera
Cytokines
Clotting Factors
Hormones
Enzymes
Enzyme Inhibitors

Segment by Application
Oncology and Haematology
Diabetes
Cardiology
Inflammatory Diseases
Others

レポート目次

Table of Contents

Global Bio-Therapeutic Glycoproteins Sales Market Report 2019
1 Bio-Therapeutic Glycoproteins Market Overview
1.1 Bio-Therapeutic GlycoproteinsProduct Overview
1.2 Bio-Therapeutic Glycoproteins Segment by Type
1.2.1 Global Bio-Therapeutic Glycoproteins Sales Comparison by Types (2014-2025)
1.2.2 Antisera
1.2.3 Cytokines
1.2.4 Clotting Factors
1.2.5 Hormones
1.2.6 Enzymes
1.2.7 Enzyme Inhibitors
1.3 Bio-Therapeutic Glycoproteins Segment by Application
1.3.1 Global Bio-Therapeutic Glycoproteins Sales Comparison by Application (2014-2025)
1.3.1 Oncology and Haematology
1.3.2 Diabetes
1.3.3 Cardiology
1.3.4 Inflammatory Diseases
1.3.5 Others
1.4 Bio-Therapeutic Glycoproteins Market by Region
1.4.1 Global Bio-Therapeutic Glycoproteins Revenue Comparison by Region (2014-2025)
1.4.2 United States Bio-Therapeutic Glycoproteins Status and Prospect (2014-2025)
1.4.3 Europe Bio-Therapeutic Glycoproteins Status and Prospect (2014-2025)
1.4.4 China Bio-Therapeutic Glycoproteins Status and Prospect (2014-2025)
1.4.5 Japan Bio-Therapeutic Glycoproteins Status and Prospect (2014-2025)
1.4.6 Southeast Asia Bio-Therapeutic Glycoproteins Status and Prospect (2014-2025)
1.4.7 India Bio-Therapeutic Glycoproteins Status and Prospect (2014-2025)
1.5 Global Bio-Therapeutic Glycoproteins Sales and Revenue (2014-2025)
1.5.1 Global Bio-Therapeutic Glycoproteins Sales and Growth Rate (2014-2025)
1.5.2 Global Bio-Therapeutic Glycoproteins Revenue and Growth Rate (2014-2025)

2 Bio-Therapeutic Glycoproteins by Company, Region, Type and Application
2.1 Global Bio-Therapeutic Glycoproteins Market Competition by Companies
2.1.1 Global Bio-Therapeutic Glycoproteins Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Bio-Therapeutic Glycoproteins Revenue Market Share by Company (2014-2019)
2.2 Global Bio-Therapeutic Glycoproteins Sales and Revenue by Region
2.2.1 Global Bio-Therapeutic Glycoproteins Sales Market Share by Region (2014-2019)
2.2.2 Global Bio-Therapeutic Glycoproteins Revenue Market Share by Region (2014-2019)
2.3 Global Bio-Therapeutic Glycoproteins Sales and Revenue by Type
2.3.1 Global Bio-Therapeutic Glycoproteins Sales Market Share by Type (2014-2019)
2.3.2 Global Bio-Therapeutic Glycoproteins Revenue Market Share by Type (2014-2019)
2.4 Global Bio-Therapeutic Glycoproteins Sales by Application

3 United States Bio-Therapeutic Glycoproteins Sales, Revenue and Price
3.1 United States Bio-Therapeutic Glycoproteins Sales and Revenue (2014-2019)
3.1.1 United States Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
3.1.2 United States Bio-Therapeutic Glycoproteins Revenue Growth Rate (2014-2019)
3.1.3 United States Bio-Therapeutic Glycoproteins Price Trend (2014-2019)
3.2 United States Bio-Therapeutic Glycoproteins Sales Market Share by Company
3.3 United States Bio-Therapeutic Glycoproteins Sales Market Share by Type
3.4 United States Bio-Therapeutic Glycoproteins Sales Market Share by Application

4 Europe Bio-Therapeutic Glycoproteins Sales, Revenue and Price
4.1 Europe Bio-Therapeutic Glycoproteins Sales and Value (2014-2019)
4.1.1 Europe Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
4.1.2 Europe Bio-Therapeutic Glycoproteins Revenue Growth Rate (2014-2019)
4.1.3 Europe Bio-Therapeutic Glycoproteins Price Trend (2014-2019)
4.2 Europe Bio-Therapeutic Glycoproteins Sales Market Share by Company
4.3 Europe Bio-Therapeutic Glycoproteins Sales Market Share by Type
4.4 Europe Bio-Therapeutic Glycoproteins Sales Market Share by Application

5 China Bio-Therapeutic Glycoproteins Sales, Revenue and Price
5.1 China Bio-Therapeutic Glycoproteins Sales and Revenue (2014-2019)
5.1.1 China Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
5.1.2 China Bio-Therapeutic Glycoproteins Revenue Growth Rate (2014-2019)
5.1.3 China Bio-Therapeutic Glycoproteins Price Trend (2014-2019)
5.2 China Bio-Therapeutic Glycoproteins Sales Market Share by Company
5.3 China Bio-Therapeutic Glycoproteins Sales Market Share by Type
5.4 China Bio-Therapeutic Glycoproteins Sales Market Share by Application

6 Japan Bio-Therapeutic Glycoproteins Sales, Revenue and Price
6.1 Japan Bio-Therapeutic Glycoproteins Sales and Value (2014-2019)
6.1.1 Japan Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
6.1.2 Japan Bio-Therapeutic Glycoproteins Revenue Growth Rate (2014-2019)
6.1.3 Japan Bio-Therapeutic Glycoproteins Price Trend (2014-2019)
6.2 Japan Bio-Therapeutic Glycoproteins Sales Market Share by Company
6.3 Japan Bio-Therapeutic Glycoproteins Sales Market Share by Type
6.4 Japan Bio-Therapeutic Glycoproteins Sales Market Share by Application

7 Southeast Asia Bio-Therapeutic Glycoproteins Sales, Revenue and Price
7.1 Southeast Asia Bio-Therapeutic Glycoproteins Sales and Value (2014-2019)
7.1.1 Southeast Asia Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Bio-Therapeutic Glycoproteins Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Bio-Therapeutic Glycoproteins Price Trend (2014-2019)
7.2 Southeast Asia Bio-Therapeutic Glycoproteins Sales Market Share by Company
7.3 Southeast Asia Bio-Therapeutic Glycoproteins Sales Market Share by Type
7.4 Southeast Asia Bio-Therapeutic Glycoproteins Sales Market Share by Application

8 India Bio-Therapeutic Glycoproteins Sales, Revenue and Price
8.1 India Bio-Therapeutic Glycoproteins Sales and Value (2014-2019)
8.1.1 India Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
8.1.2 India Bio-Therapeutic Glycoproteins Revenue Growth Rate (2014-2019)
8.1.3 India Bio-Therapeutic Glycoproteins Price Trend (2014-2019)
8.2 India Bio-Therapeutic Glycoproteins Sales Market Share by Company
8.3 India Bio-Therapeutic Glycoproteins Sales Market Share by Type
8.4 India Bio-Therapeutic Glycoproteins Sales Market Share by Application

9 Company Profiles and Key Figures in Bio-Therapeutic Glycoproteins Business
9.1 Genentech
9.1.1 Genentech Bio-Therapeutic Glycoproteins Production Sites and Area Served
9.1.2 Bio-Therapeutic Glycoproteins Specification and Application
9.1.3 Genentech Bio-Therapeutic Glycoproteins Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 Hoffmann-La Roche
9.2.1 Hoffmann-La Roche Bio-Therapeutic Glycoproteins Production Sites and Area Served
9.2.2 Bio-Therapeutic Glycoproteins Specification and Application
9.2.3 Hoffmann-La Roche Bio-Therapeutic Glycoproteins Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 Genzyme Corp
9.3.1 Genzyme Corp Bio-Therapeutic Glycoproteins Production Sites and Area Served
9.3.2 Bio-Therapeutic Glycoproteins Specification and Application
9.3.3 Genzyme Corp Bio-Therapeutic Glycoproteins Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Abbott Laboratories
9.4.1 Abbott Laboratories Bio-Therapeutic Glycoproteins Production Sites and Area Served
9.4.2 Bio-Therapeutic Glycoproteins Specification and Application
9.4.3 Abbott Laboratories Bio-Therapeutic Glycoproteins Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 Amgen
9.5.1 Amgen Bio-Therapeutic Glycoproteins Production Sites and Area Served
9.5.2 Bio-Therapeutic Glycoproteins Specification and Application
9.5.3 Amgen Bio-Therapeutic Glycoproteins Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
9.6 Biogen
9.6.1 Biogen Bio-Therapeutic Glycoproteins Production Sites and Area Served
9.6.2 Bio-Therapeutic Glycoproteins Specification and Application
9.6.3 Biogen Bio-Therapeutic Glycoproteins Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business and Markets Served
9.7 Merck
9.7.1 Merck Production Sites and Area Served
9.7.2 Bio-Therapeutic Glycoproteins Specification and Application
9.7.3 Merck Bio-Therapeutic Glycoproteins Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Main Business and Markets Served
9.8 GlaxoSmithKline
9.8.1 GlaxoSmithKline Bio-Therapeutic Glycoproteins Production Sites and Area Served
9.8.2 Bio-Therapeutic Glycoproteins Specification and Application
9.8.3 GlaxoSmithKline Bio-Therapeutic Glycoproteins Sales, Revenue, Price and Gross Margin (2014-2019)
9.8.4 Main Business and Markets Served
9.9 Novartis Pharmaceuticals Corp
9.9.1 Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Production Sites and Area Served
9.9.2 Bio-Therapeutic Glycoproteins Specification and Application
9.9.3 Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Sales, Revenue, Price and Gross Margin (2014-2019)
9.9.4 Main Business and Markets Served

10 Bio-Therapeutic Glycoproteins Maufacturing Cost Analysis
10.1 Bio-Therapeutic Glycoproteins Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Bio-Therapeutic Glycoproteins
10.4 Bio-Therapeutic Glycoproteins Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Bio-Therapeutic Glycoproteins Distributors List
11.3 Bio-Therapeutic Glycoproteins Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 Bio-Therapeutic Glycoproteins Market Forecast
13.1 Global Bio-Therapeutic Glycoproteins Sales, Revenue and Price Forecast
13.1.1 Global Bio-Therapeutic Glycoproteins Sales Growth Forecast (2019-2025)
13.1.2 Global Bio-Therapeutic Glycoproteins Revenue Growth Forecast (2019-2025)
13.1.3 Global Bio-Therapeutic Glycoproteins Price Trend Forecast (2019-2025)
13.2 Global Bio-Therapeutic Glycoproteins Forecast by Region
13.2.1 Global Bio-Therapeutic Glycoproteins Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Bio-Therapeutic Glycoproteins Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Bio-Therapeutic Glycoproteins Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Bio-Therapeutic Glycoproteins Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Bio-Therapeutic Glycoproteins Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Bio-Therapeutic Glycoproteins Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Bio-Therapeutic Glycoproteins Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Bio-Therapeutic Glycoproteins Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Bio-Therapeutic Glycoproteins Forecast by Type
13.3.1 Global Bio-Therapeutic Glycoproteins Sales Forecast by Type (2019-2025)
13.3.2 Global Bio-Therapeutic Glycoproteins Revenue Forecast by Type (2019-2025)
13.3.3 Global Bio-Therapeutic Glycoproteins Price Forecast by Type (2019-2025)
13.4 Global Bio-Therapeutic Glycoproteins Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

List of Tables and Figures

Market Breakdown by Region: Bio-Therapeutic Glycoproteins Sales (K MT) and Value (Revenue: Million US$)
Market Breakdown by Type: Bio-Therapeutic Glycoproteins Sales (K MT) and Revenue (Million US$)
Market Breakdown by Application: Bio-Therapeutic Glycoproteins Sales (Jan)
Figure Bio-Therapeutic Glycoproteins Product Picture
Table Global Bio-Therapeutic Glycoproteins Sales (K MT) Growth Rate by Types (2014-2025)
Figure Global Bio-Therapeutic Glycoproteins Sales Market Share by Types in 2018
Figure Antisera Product Picture
Figure Cytokines Product Picture
Figure Clotting Factors Product Picture
Figure Hormones Product Picture
Figure Enzymes Product Picture
Figure Enzyme Inhibitors Product Picture
Table Global Bio-Therapeutic Glycoproteins Sales (K MT) Comparison by Application (2014-2025)
Figure Global Sales Market Share of Bio-Therapeutic Glycoproteins by Application in 2018
Figure Oncology and Haematology Examples
Figure Diabetes Examples
Figure Cardiology Examples
Figure Inflammatory Diseases Examples
Figure Others Examples
Table Global Market Bio-Therapeutic Glycoproteins Revenue (Million USD) Comparison by Region 2014-2025
Figure United States Bio-Therapeutic Glycoproteins Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Bio-Therapeutic Glycoproteins Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Bio-Therapeutic Glycoproteins Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Bio-Therapeutic Glycoproteins Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Bio-Therapeutic Glycoproteins Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Bio-Therapeutic Glycoproteins Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Bio-Therapeutic Glycoproteins Sales (K MT) Growth Rate (2014-2025)
Figure Global Bio-Therapeutic Glycoproteins Revenue (Million USD) Growth Rate (2014-2025)
Table Global Bio-Therapeutic Glycoproteins Sales (K MT) of Key Companies (2014-2019)
Figure Global Bio-Therapeutic Glycoproteins Sales by Company in 2018
Table Global Bio-Therapeutic Glycoproteins Sales Share by Company (2014-2019)
Figure Global Bio-Therapeutic Glycoproteins Sales Share by Company in 2018
Table Global Bio-Therapeutic Glycoproteins Revenue (Million USD) by Company (2014-2019)
Figure Global Bio-Therapeutic Glycoproteins Revenue (Million USD) by Company in 2018
Table Global Bio-Therapeutic Glycoproteins Revenue Share by Company (2014-2019)
Figure Global Bio-Therapeutic Glycoproteins Revenue Share by Company in 2018
Table Global Bio-Therapeutic Glycoproteins Sales (K MT) Market Share by Region (2014-2019)
Table Global Bio-Therapeutic Glycoproteins Sales Share by Region (2014-2019)
Figure Global Bio-Therapeutic Glycoproteins Sales Share by Region in 2018
Table Global Bio-Therapeutic Glycoproteins Revenue (Million USD) Market Share by Region (2014-2019)
Table Global Bio-Therapeutic Glycoproteins Revenue Share by Region (2014-2019)
Figure Global Bio-Therapeutic Glycoproteins Revenue Market Share by Region In 2018
Table Global Bio-Therapeutic Glycoproteins Sales (K MT) by Type (2014-2019)
Table Global Bio-Therapeutic Glycoproteins Sales Share by Type (2014-2019)
Figure Global Bio-Therapeutic Glycoproteins Sales Growth Rate by Type in 2018
Table Global Bio-Therapeutic Glycoproteins Revenue (Million USD) Market Share by Type (2014-2019)
Table Global Bio-Therapeutic Glycoproteins Revenue Share by Type (2014-2019)
Figure Global Bio-Therapeutic Glycoproteins Revenue Growth Rate by Type in 2018
Table Global Bio-Therapeutic Glycoproteins Sales Market Share by Application (2014-2019)
Table Global Bio-Therapeutic Glycoproteins Sales Share by Application (2014-2019)
Figure Global Bio-Therapeutic Glycoproteins Sales Market Share by Application in 2018
Figure United States Bio-Therapeutic Glycoproteins Sales (K MT) and Growth Rate (2014-2019)
Figure United States Bio-Therapeutic Glycoproteins Revenue (Million USD) and Growth Rate (2014-2019)
Figure United States Bio-Therapeutic Glycoproteins Price (USD/MT) Trend (2014-2019)
Table United States Bio-Therapeutic Glycoproteins Sales (K MT) by Company (2014-2019)
Table United States Bio-Therapeutic Glycoproteins Sales Market Share by Company (2014-2019)
Figure United States Bio-Therapeutic Glycoproteins Sales Market Share by Company in 2018
Table United States Bio-Therapeutic Glycoproteins Sales (K MT) by Type (2014-2019)
Table United States Bio-Therapeutic Glycoproteins Sales Market Share by Type (2014-2019)
Figure United States Bio-Therapeutic Glycoproteins Sales Market Share by Type in 2018
Table United States Bio-Therapeutic Glycoproteins Sales (K MT) by Application (2014-2019)
Table United States Bio-Therapeutic Glycoproteins Sales Market Share by Application (2014-2019)
Figure United States Bio-Therapeutic Glycoproteins Sales Market Share by Application in 2018
Figure Europe Bio-Therapeutic Glycoproteins Sales (K MT) and Growth Rate (2014-2019)
Figure Europe Bio-Therapeutic Glycoproteins Revenue (Million USD) and Growth Rate (2014-2019)
Figure Europe Bio-Therapeutic Glycoproteins Price (USD/MT) Trend (2014-2019)
Table Europe Bio-Therapeutic Glycoproteins Sales (K MT) by Company (2014-2019)
Table Europe Bio-Therapeutic Glycoproteins Sales Market Share by Company (2014-2019)
Figure Europe Bio-Therapeutic Glycoproteins Sales Market Share by Company in 2018
Table Europe Bio-Therapeutic Glycoproteins Sales (K MT) by Type (2014-2019)
Table Europe Bio-Therapeutic Glycoproteins Sales Market Share by Type (2014-2019)
Figure Europe Bio-Therapeutic Glycoproteins Sales Market Share by Type in 2018
Table Europe Bio-Therapeutic Glycoproteins Sales (K MT) by Application (2014-2019)
Table Europe Bio-Therapeutic Glycoproteins Sales Market Share by Application (2014-2019)
Figure Europe Bio-Therapeutic Glycoproteins Sales Market Share by Application in 2018
Figure China Bio-Therapeutic Glycoproteins Sales (K MT) and Growth Rate (2014-2019)
Figure China Bio-Therapeutic Glycoproteins Revenue (Million USD) and Growth Rate (2014-2019)
Figure China Bio-Therapeutic Glycoproteins Price (USD/MT) Trend (2014-2019)
Table China Bio-Therapeutic Glycoproteins Sales (K MT) by Company (2014-2019)
Table China Bio-Therapeutic Glycoproteins Sales Market Share by Company (2014-2019)
Figure China Bio-Therapeutic Glycoproteins Sales Market Share by Company in 2018
Table China Bio-Therapeutic Glycoproteins Sales (K MT) by Type (2014-2019)
Table China Bio-Therapeutic Glycoproteins Sales Market Share by Type (2014-2019)
Figure China Bio-Therapeutic Glycoproteins Sales Market Share by Type in 2018
Table China Bio-Therapeutic Glycoproteins Sales (K MT) by Application (2014-2019)
Table China Bio-Therapeutic Glycoproteins Sales Market Share by Application (2014-2019)
Figure China Bio-Therapeutic Glycoproteins Sales Market Share by Application in 2018
Figure Japan Bio-Therapeutic Glycoproteins Sales (K MT) and Growth Rate (2014-2019)
Figure Japan Bio-Therapeutic Glycoproteins Revenue (Million USD) and Growth Rate (2014-2019)
Figure Japan Bio-Therapeutic Glycoproteins Price (USD/MT) Trend (2014-2019)
Table Japan Bio-Therapeutic Glycoproteins Sales (K MT) by Company (2014-2019)
Table Japan Bio-Therapeutic Glycoproteins Sales Market Share by Company (2014-2019)
Figure Japan Bio-Therapeutic Glycoproteins Sales Market Share by Company in 2018
Table Japan Bio-Therapeutic Glycoproteins Sales (K MT) by Type (2014-2019)
Table Japan Bio-Therapeutic Glycoproteins Sales Market Share by Type (2014-2019)
Figure Japan Bio-Therapeutic Glycoproteins Sales Market Share by Type in 2018
Table Japan Bio-Therapeutic Glycoproteins Sales (K MT) by Application (2014-2019)
Table Japan Bio-Therapeutic Glycoproteins Sales Market Share by Application (2014-2019)
Figure Japan Bio-Therapeutic Glycoproteins Sales Market Share by Application in 2018
Figure Southeast Asia Bio-Therapeutic Glycoproteins Sales (K MT) and Growth Rate (2014-2019)
Figure Southeast Asia Bio-Therapeutic Glycoproteins Revenue (Million USD) and Growth Rate (2014-2019)
Figure Southeast Asia Bio-Therapeutic Glycoproteins Price (USD/MT) Trend (2014-2019)
Table Southeast Asia Bio-Therapeutic Glycoproteins Sales (K MT) by Company (2014-2019)
Table Southeast Asia Bio-Therapeutic Glycoproteins Sales Market Share by Company (2014-2019)
Figure Southeast Asia Bio-Therapeutic Glycoproteins Sales Market Share by Company in 2018
Table Southeast Asia Bio-Therapeutic Glycoproteins Sales (K MT) by Type (2014-2019)
Table Southeast Asia Bio-Therapeutic Glycoproteins Sales Market Share by Type (2014-2019)
Figure Southeast Asia Bio-Therapeutic Glycoproteins Sales Market Share by Type in 2018
Table Southeast Asia Bio-Therapeutic Glycoproteins Sales (K MT) by Application (2014-2019)
Table Southeast Asia Bio-Therapeutic Glycoproteins Sales Market Share by Application (2014-2019)
Figure Southeast Asia Bio-Therapeutic Glycoproteins Sales Market Share by Application in 2018
Figure India Bio-Therapeutic Glycoproteins Sales (K MT) and Growth Rate (2014-2019)
Figure India Bio-Therapeutic Glycoproteins Revenue (Million USD) and Growth Rate (2014-2019)
Figure India Bio-Therapeutic Glycoproteins Price (USD/MT) Trend (2014-2019)
Table India Bio-Therapeutic Glycoproteins Sales (K MT) by Company (2014-2019)
Table India Bio-Therapeutic Glycoproteins Sales Market Share by Company (2014-2019)
Figure India Bio-Therapeutic Glycoproteins Sales Market Share by Company in 2018
Table India Bio-Therapeutic Glycoproteins Sales (K MT) by Type (2014-2019)
Table India Bio-Therapeutic Glycoproteins Sales Market Share by Type (2014-2019)
Figure India Bio-Therapeutic Glycoproteins Sales Market Share by Type in 2018
Table India Bio-Therapeutic Glycoproteins Sales (K MT) by Application (2014-2019)
Table India Bio-Therapeutic Glycoproteins Sales Market Share by Application (2014-2019)
Figure India Bio-Therapeutic Glycoproteins Sales Market Share by Application in 2018
Table Genentech Bio-Therapeutic Glycoproteins Production Sites and Area Served
Table Genentech Bio-Therapeutic Glycoproteins Specification and Application
Table Genentech Bio-Therapeutic Glycoproteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Figure Genentech Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
Figure Genentech Bio-Therapeutic Glycoproteins Revenue Share in International Market (2014-2019)
Figure Genentech Bio-Therapeutic Glycoproteins Main Business and Markets Served
Table Hoffmann-La Roche Bio-Therapeutic Glycoproteins Production Sites and Area Served
Table Hoffmann-La Roche Bio-Therapeutic Glycoproteins Specification and Application
Table Hoffmann-La Roche Bio-Therapeutic Glycoproteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Figure Hoffmann-La Roche Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
Figure Hoffmann-La Roche Bio-Therapeutic Glycoproteins Revenue Share in International Market (2014-2019)
Figure Hoffmann-La Roche Bio-Therapeutic Glycoproteins Main Business and Markets Served
Table Genzyme Corp Bio-Therapeutic Glycoproteins Production Sites and Area Served
Table Genzyme Corp Bio-Therapeutic Glycoproteins Specification and Application
Table Genzyme Corp Bio-Therapeutic Glycoproteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Figure Genzyme Corp Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
Figure Genzyme Corp Bio-Therapeutic Glycoproteins Revenue Share in International Market (2014-2019)
Figure Genzyme Corp Bio-Therapeutic Glycoproteins Main Business and Markets Served
Table Abbott Laboratories Bio-Therapeutic Glycoproteins Production Sites and Area Served
Table Abbott Laboratories Bio-Therapeutic Glycoproteins Specification and Application
Table Abbott Laboratories Bio-Therapeutic Glycoproteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Figure Abbott Laboratories Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
Figure Abbott Laboratories Bio-Therapeutic Glycoproteins Revenue Share in International Market (2014-2019)
Figure Abbott Laboratories Bio-Therapeutic Glycoproteins Main Business and Markets Served
Table Amgen Bio-Therapeutic Glycoproteins Production Sites and Area Served
Table Amgen Bio-Therapeutic Glycoproteins Specification and Application
Table Amgen Bio-Therapeutic Glycoproteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Figure Amgen Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
Figure Amgen Bio-Therapeutic Glycoproteins Revenue Share in International Market (2014-2019)
Figure Amgen Bio-Therapeutic Glycoproteins Main Business and Markets Served
Table Biogen Bio-Therapeutic Glycoproteins Production Sites and Area Served
Table Biogen Bio-Therapeutic Glycoproteins Specification and Application
Table Biogen Bio-Therapeutic Glycoproteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Figure Biogen Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
Figure Biogen Bio-Therapeutic Glycoproteins Revenue Share in International Market (2014-2019)
Figure Biogen Bio-Therapeutic Glycoproteins Main Business and Markets Served
Table Merck Bio-Therapeutic Glycoproteins Production Sites and Area Served
Table Merck Bio-Therapeutic Glycoproteins Specification and Application
Table Merck Bio-Therapeutic Glycoproteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Figure Merck Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
Figure Merck Bio-Therapeutic Glycoproteins Revenue Share in International Market (2014-2019)
Figure Merck Bio-Therapeutic Glycoproteins Main Business and Markets Served
Table GlaxoSmithKline Bio-Therapeutic Glycoproteins Production Sites and Area Served
Table GlaxoSmithKline Bio-Therapeutic Glycoproteins Specification and Application
Table GlaxoSmithKline Bio-Therapeutic Glycoproteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Figure GlaxoSmithKline Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
Figure GlaxoSmithKline Bio-Therapeutic Glycoproteins Revenue Share in International Market (2014-2019)
Figure GlaxoSmithKline Bio-Therapeutic Glycoproteins Main Business and Markets Served
Table Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Production Sites and Area Served
Table Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Specification and Application
Table Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Figure Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Sales Growth Rate (2014-2019)
Figure Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Revenue Share in International Market (2014-2019)
Figure Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Key Raw Materials Price Trend
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bio-Therapeutic Glycoproteins
Figure Manufacturing Process Analysis of Bio-Therapeutic Glycoproteins
Figure Bio-Therapeutic Glycoproteins Industrial Chain Analysis
Table Bio-Therapeutic Glycoproteins Distributors List
Table Bio-Therapeutic Glycoproteins Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Bio-Therapeutic Glycoproteins Sales (K MT) and Growth Rate Forecast (2019-2025)
Figure Global Bio-Therapeutic Glycoproteins Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Bio-Therapeutic Glycoproteins Price (USD/MT) and Trend Forecast (2019-2025)
Table Global Bio-Therapeutic Glycoproteins Sales (K MT) Forecast by Regions (2019-2025)
Figure Global Bio-Therapeutic Glycoproteins Sales Market Share Forecast by Regions (2019-2025)
Figure Global Bio-Therapeutic Glycoproteins Sales Market Share Forecast by Regions in 2025
Table Global Bio-Therapeutic Glycoproteins Revenue (Million USD) Forecast by Regions (2019-2025)
Figure Global Bio-Therapeutic Glycoproteins Revenue Market Share Forecast by Regions (2019-2025)
Figure Global Bio-Therapeutic Glycoproteins Revenue Market Share Forecast by Regions in 2025
Figure United States Bio-Therapeutic Glycoproteins Sales (K MT) and Growth Rate Forecast (2019-2025)
Figure United States Bio-Therapeutic Glycoproteins Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Bio-Therapeutic Glycoproteins Sales (K MT) and Growth Rate Forecast (2019-2025)
Figure Europe Bio-Therapeutic Glycoproteins Revenue and Growth Rate Forecast (2019-2025)
Figure China Bio-Therapeutic Glycoproteins Sales (K MT) and Growth Rate Forecast (2019-2025)
Figure China Bio-Therapeutic Glycoproteins Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Bio-Therapeutic Glycoproteins Sales (K MT) and Growth Rate Forecast (2019-2025)
Figure Japan Bio-Therapeutic Glycoproteins Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Bio-Therapeutic Glycoproteins Sales (K MT) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Bio-Therapeutic Glycoproteins Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure India Bio-Therapeutic Glycoproteins Sales (K MT) and Growth Rate Forecast (2019-2025)
Figure India Bio-Therapeutic Glycoproteins Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Bio-Therapeutic Glycoproteins Sales (K MT) Forecast by Type (2019-2025)
Figure Global Bio-Therapeutic Glycoproteins Sales Market Share Forecast by Type (2019-2025)
Table Global Bio-Therapeutic Glycoproteins Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Bio-Therapeutic Glycoproteins Revenue Market Share Forecast by Type (2019-2025)
Table Global Bio-Therapeutic Glycoproteins Price (USD/MT) Forecast by Type (2019-2025)
Table Global Bio-Therapeutic Glycoproteins Sales (K MT) Forecast by Application (2019-2025)
Figure Global Bio-Therapeutic Glycoproteins Sales Market Share Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources